Jamylene

Docusate Sodium, the active ingredient in Jamylene, is a surfactant laxative presented as an oral formulation for oral use. It is used to soften stool and relieve occasional constipation in adults and children. GNH USA supplies Jamylene as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jamylene, a surfactant laxative, works within the gastrointestinal tract to ease bowel movements in patients with constipation. - Mild constipation: Softens stool to allow gentle passage without straining. - Chronic constipation: Provides regular stool softening for ongoing bowel regularity. - Occasional constipation: Offers rapid relief for sporadic difficulty in defecation.

Common Side Effects: - Abdominal cramping: Mild discomfort in the lower abdomen. - Flatulence: Increased gas production. - Nausea: Transient feeling of queasiness. - Mild diarrhea: Loose stools if excess dose is taken. - Throat irritation: Possible with liquid formulations. Serious or Rare Side Effects: - Severe abdominal pain: Persistent or worsening pain requiring medical attention. - Electrolyte imbalance: Uncommon but possible with prolonged use. - Allergic reaction: Rash, itching, or swelling. - Rectal bleeding: Unexplained blood in stool.

Before using Jamylene, consider the following precautions: - Hydration: Ensure adequate fluid intake to support stool softening. - Duration of use: Limit use to short periods unless directed by a healthcare professional. - Bowel obstruction: Do not use if a mechanical obstruction is suspected. - Underlying conditions: Consult a clinician for chronic gastrointestinal diseases. - Pregnancy and breastfeeding: Discuss use with a healthcare provider. - Store at below 25°C: Keep in the original packaging, protect from moisture and heat.

Jamylene may interact with other agents that affect gastrointestinal function. Major Interactions (Avoid): - Mineral oil: Reduces the stool‑softening effect. - Cholesterol‑binding resins (e.g., cholestyramine): May decrease absorption. - Orlistat: Can diminish efficacy of the laxative. Moderate Interactions (Monitor Closely): - Iron supplements: May alter stool consistency. - Calcium carbonate: Potential for reduced laxative effect. - Vitamin D preparations: Observe for any change in bowel habits.